FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

The Food and Drug Administration (FDA) authorized Novavax’s COVID vaccine for adults on Wednesday, offering a protein-based alternative to mRNA shots from other pharmaceutical companies.

The newly authorized vaccine is scheduled in two doses separated by 21 days.

READ MORE
 

FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

Next to Join Abraham Accords

The head of Israel’s foreign ministry’s bureau of the Middle…
Read more
FDA Authorizes Novavax COVID Vaccine

Robot Policing Undesirable Social Behavior

Singapore is one of the safest countries and cities in the…
Read more
FDA Authorizes Novavax COVID Vaccine

German SPD Expects To Lead New Coalition

Germany’s Social Democrats began in-depth exploratory coalition…
Read more